Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|April 26, 2005
Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trialA Galioto, P Angeli, S Guarda, et al.
Journal of Hepatology|February 11, 2014
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefitA Vitale, A Cucchetti, G L Qiao, et al.
Transplantation Proceedings|June 27, 2003
Extreme marginal donor: severe hypothermia as a rare preservation condition for explantable organs--a case reportA Brolese, M Bassanello, U Cillo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteriaU Cillo, A Vitale, F Grigoletto, et al.
Transplantation Proceedings|September 17, 2013
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experienceI Bortoluzzi, M Gambato, L Albertoni, et al.
Transplantation Proceedings|May 2, 2017
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case ReportG Zanus, M Romano, M Finotti, et al.
Transplantation Proceedings|December 31, 2003
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timingM Bassanello, A Vitale, F A Ciarleglio, et al.
Transplantation Proceedings|September 15, 2012
Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme caseE Gringeri, F E D'Amico, D Bassi, et al.
ESMO Open|April 11, 2025
Claudin 18.2: a promising actionable target in biliary tract cancersV Angerilli, D Sacchi, M Rizzato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literatureD Pastorelli, G Cartei, F Zustovich, et al.
Pageof 9